Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

Fig. 1

Plasma viral load and CD4 cell count follow-up from 2008 to 2016 in Case 1. Arrow indicates the time of switching to DTG/RPV dual therapy. X + 0 indicates the time of first administration of anti-retroviral drugs. Abbreviations: TDF/FTC, tenofovir/emtricitabine; ABC/3Tc, abacavir/lamivudine; RPV, rilpivirine; DRV/r, darunavir/ritonavir; MVC, maraviroc; RAL, raltegravir; DTG, dolutegravir

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us